GnuBIO Secures $10 Million in Series B Financing
October 4, 2012
Cambridge, MA - GnuBIO, today announced that it has completed a $10 million Series B round of equity financing from a group of private investors which include existing Series A shareholders. The funding will be used to commercialize the company’s desktop DNA sequencing platform, hire additional staff in product development, molecular biology, informatics and software [...]
PG&E To Expand Deployment Of Picarro’s Cutting-Edge Gas Leak Detection Technology
October 4, 2012
SAN FRANCISCO & SANTA CLARA, Calif., – Pacific Gas and Electric Company (PG&E) and Picarro Inc. today announced an expanded collaboration to further advance the safety of the utility’s natural gas pipelines. PG&E will deploy six Picarro SurveyorTM devices for vehicle-mounted, super-sensitive gas leak detection throughout its Northern and Central California service area - making [...]
October 4, 2012
KARLSRUHE, Germany -- Bruker today announces three new orders for DNP-NMR research systems, including a 395 GHz DNP-NMR system, as well as two 263 GHz DNP-NMR systems or major upgrades. This breakthrough new DNP hyperpolarization technology will soon be available at the Universities of Düsseldorf, Darmstadt and Frankfurt for use in life science and materials [...]
SevenExcellence™Precise, Flexible and Secure pH, Ion and Conductivity Instruments
October 4, 2012
Columbus, OH – METTLER TOLEDO announces the introduction of SevenExcellence™, a revolutionary benchtop meter for precise measurements of pH, conductivity, ion concentration or ORP (oxidation reduction potential). SevenExcellence is a modular instrument that measures one, two or three channels in parallel. Operation is intuitive thanks to its unique 7-inch touch screen and its ingenious guided [...]
Arrayit Diagnostics, Inc. Announces $8 Million Financing Commitment
October 4, 2012
SUNNYVALE, Calif., -- Arrayit Corporation (OTCQB: ARYC) is pleased to announce that Arrayit Diagnostics, Inc. (“”AD””) has secured a financing commitment from American Equity Fund, LLC to purchase up to $8 million of the common stock of AD. This financing will commence upon the completion, filing, and approval by the SEC of the S-1 Registration [...]
Protea expands its global distribution network
October 4, 2012
Protea Biosciences Group, Inc., Morgantown, WV; 8:30am EST October 04, 2012 – Protea, a leader in the field of bioanalytics, announced today it has established new international distributor partnerships, in Israel (Yair Technologies), Poland (BioAnalytic), Spain and Portugal (Irida Iberica S.L.), and Turkey (IDL Teknolojik). “These new distribution agreements reflect our continued, successful expansion of [...]
October 4, 2012
TAP Biosystems, a leading supplier of innovative cell culture systems and consumables for life science applications, is pleased to announce a new collaboration with researchers at University College London (UCL) in the UK to develop solid tumour tissue models using its RAFT 3D cell culture system for use in drug discovery applications. The three way [...]
October 4, 2012
Redwood City, CA –– Ingenuity Systems®, a leading provider of biomedical information and analysis solutions, today announced Ingenuity iReport now supports analysis and interpretation of human isoform-level RNA sequencing data. Ingenuity iReport for Isoform-level Human RNA-Seq data enables researchers to quickly and easily identify significantly regulated isoforms, interpreting the impact of those expression changes in [...]
ImmunoReagents Signs South Korean Distributorship Agreement with Sungwoo Life Sciences
October 4, 2012
Raleigh, NC, -- ImmunoReagents, a manufacturer of high quality polyclonal antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Sungwoo Life Sciences as its new distributor in South Korea. ImmunoReagents and Sungwoo will partner to distribute top quality antibodies to the South Korean biotech, life science, and medical communities. South Korea [...]
Horizon Discovery Launches SyntheTx Partnership Program for Cancer Therapeutics
October 4, 2012
Cambridge, UK, and Cambridge, MA,: Horizon Discovery Ltd (Horizon), a leading provider of research tools to support the development of personalized medicines, and H3 Biomedicine Inc. today announced the launch of SyntheTx, a technology partnership program aiming to become a major supplier of novel oncology targets and early-stage drug discovery programs to the pharmaceutical industry. [...]
